Ondansetron: From PONV to tardive dyskinesia?

Nissen, Lisa (2010) Ondansetron: From PONV to tardive dyskinesia?. Australian Pharmacist, 29 12: 1020-1021.

Attached Files (Some files may be inaccessible until you login with your UQ eSpace credentials)
Name Description MIMEType Size Downloads
Author Nissen, Lisa
Title Ondansetron: From PONV to tardive dyskinesia?
Journal name Australian Pharmacist   Check publisher's open access policy
ISSN 0728-4632
Publication date 2010-12
Sub-type Article (original research)
Volume 29
Issue 12
Start page 1020
End page 1021
Total pages 2
Editor J. Wissman
Place of publication Curtin, ACT, Australia
Publisher Pharmaceutical Society of Australia
Collection year 2011
Language eng
Formatted abstract
The benefits and advantages offered by treatment with Ondansetron in the case of patients suffering from tardive dyskinesia (TD) that often occur in patients treated with long-term dopaminergic antagonist medications are discussed. Ondansetron is a well tolerated medication and is especially useful in cases where patients have refused to respond to other treatments.
Keyword Tardive dyskinesia - chemotherapy
Drugs - dosage
Postoperative nausea and vomiting
Drugs - efectiveness
Q-Index Code C1
Q-Index Status Confirmed Code
Institutional Status UQ

Document type: Journal Article
Sub-type: Article (original research)
Collections: Official 2011 Collection
School of Pharmacy Publications
Version Filter Type
Citation counts: Google Scholar Search Google Scholar
Created: Mon, 07 Mar 2011, 11:22:55 EST by Charna Kovacevic on behalf of School of Pharmacy